A 12-week multicenter, randomized, double-blind, paralle

Project: Research project

Project Details

Description

A 12-week multicenter, randomized, double-blind, parallel-group, active-control study to evaluate the antihypertensive efficacy and safety of an Exforge?? (valsarten/ amlodipine)-based regimen versus a losarten-based regimen in patients with Stage 2 syst
StatusFinished
Effective start/end date4/6/099/30/10

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.